国际口腔医学杂志

国际口腔医学杂志 ›› 2025, Vol. 52 ›› Issue (5): 670-676.doi: 10.7518/gjkq.2025090

• 综述 • 上一篇    下一篇

服用抗血栓药物患者牙周基础治疗期间的出血风险管理

朱然(),严静,孙卫斌,吴文蕾,刘玉()   

  1. 南京大学医学院附属口腔医院·南京市口腔医院高级专家诊疗中心南京大学口腔医学研究所 南京 210008
  • 收稿日期:2024-09-19 修回日期:2025-03-05 出版日期:2025-09-01 发布日期:2025-08-27
  • 通讯作者: 刘玉
  • 作者简介:朱然，住院医师，学士，Email：1027709099@qq.com
  • 基金资助:
    国家自然科学基金面上项目(51972167);江苏省干部保健科研课题(BJ21006);南京大学医学院附属口腔医院“3456”育才计划(0222E304);南京市卫生科技发展专项资金项目(GAX24300)

Management of patients undergoing basic periodontal therapy while receiving antithrombotic drugs

Ran Zhu(),Jing Yan,Weibin Sun,Wenlei Wu,Yu Liu()   

  1. Dept. of Advanced Specialist Clinic, Nanjing Stomatological Hospital, Affiliated Stomatological Hospital of Medical School, Nanjing University, Institute of Stomatology, Nanjing University, Nanjing 210008, China
  • Received:2024-09-19 Revised:2025-03-05 Online:2025-09-01 Published:2025-08-27
  • Contact: Yu Liu
  • Supported by:
    General Program of National Natural Science Foundation of China(51972167);Jiangsu Provincial Cadre Health Care Research Projects(BJ21006);"3456" Cultivation Program for Junior Talents of Nanjing Stomatological Hospital, Medical School of Nanjing University(0222E304);Nanjing Health Science and Technology Development Special Fund Project(GAX24300)

RichHTML

1

PDF (PC)

4

摘要：

牙周病是口腔常见的慢性炎症性疾病。尽管口腔医生治疗牙周疾病的经验丰富，但长期服用抗血栓药物的患者通常全身情况复杂且个体差异大，在牙周基础治疗前的药物管理策略尚存在争议。在临床治疗中，患者可能自行更改药物方案，忽视了因停药而引起的血栓潜在风险。牙周基础治疗前，对服用抗血栓药物的患者进行风险评估，有助于降低患者出血和血栓风险。本文总结了该类患者牙周基础治疗期间药物方案和牙周治疗方案制定策略、药物使用注意事项及术中术后出血处理，以帮助医生合理制定个性化诊疗方案。

关键词: 牙周炎, 牙周基础治疗, 抗血栓药物

Abstract:

Periodontal disease is a common chronic inflammatory disease of the oral cavity. Although dentists are experienced in the management of periodontal disease, the treatment of patients receiving long-term antithrombotic therapy presents additional challenges because of their often complex systemic conditions and considerable interindividual varia-bility. The management of antithrombotic medications prior to basic periodontal therapy remains a subject of ongoing debate. In clinical practice, patients may independently alter their medication regimens, frequently underestimating the increased risk of thrombotic events associated with the discontinuation of these drugs. Comprehensive risk assessment prior to initiating periodontal therapy is essential to minimize bleeding and thrombotic complications. This article reviews current strategies for developing individualized periodontal treatment plans, outlines precautions related to antithrombotic drug use, and discusses the management of intraoperative and postoperative bleeding. The aim is to support clinicians in formulating rational and patient-specific approaches to basic periodontal treatment for individuals on antithrombotic the-rapy.

Key words: periodontal disease, basic periodontal therapy, antithrombotic drug

中图分类号: 

  • R781.4
[1] Sanz M, Herrera D, Kebschull M, et al. Treatment of stage Ⅰ-Ⅲ periodontitis-the EFP S3 level clinical practice guideline[J]. J Clin Periodontol, 2020, 47(): 4-60.
[2] Ghuman MS. Non-surgical periodontal therapy-evidence and opinion[J]. Prim Dent J, 2020, 8(4): 28-33.
[3] 朱思颖, 季瑾, 刘怡, 等. 长期服用阿司匹林的慢性牙周炎患者对全口龈上超声洁治前后出凝血影响的研究[J]. 中国医刊, 2023, 58(11): 1260-1263.
Zhu SY, Ji J, Liu Y, et al. Study on the effect of coa-gulation before and after whole-mouth supragingival ultrasonic cleaning in chronic periodontitis patients on long-term aspirin use[J]. Chin J Med, 2023, 58(11): 1260-1263.
[4] Calcia TBB, Oballe HJR, de Oliveira Silva AM, et al. Is alteration in single drug anticoagulant/antiplatelet regimen necessary in patients who need minor oral surgery? A systematic review with meta-analysis[J]. Clin Oral Investig, 2021, 25(6): 3369-3381.
[5] 杨宝峰, 陈建国. 药理学[M]. 9版. 北京: 人民卫生出版社, 2018: 260-270.
Yang BF, Chen JG. Pharmacology[M]. 9th ed. Beijing: People’s Medical Publishing House, 2018: 260-270.
[6] Boschitz D, Fastowiec DM, Bolliger D. Update on perioperative antithrombotic management[J]. Curr Anesthesiol Rep, 2024, 14(3): 407-416.
[7] Heestermans M, Poenou G, Hamzeh-Cognasse H, et al. Anticoagulants: a short history, their mechanism of action, pharmacology, and indications[J]. Cells, 2022, 11(20): 3214.
[8] Stanger L, Yamaguchi A, Holinstat M. Antiplatelet strategies: past, present, and future[J]. J Thromb Haemost, 2023, 21(12): 3317-3328.
[9] Krishnan B, Prasad GA, Madhan B, et al. Post-extraction bleeding complications in patients on uninterrupted dual antiplatelet therapy-a prospective study[J]. Clin Oral Investig, 2021, 25(2): 507-514.
[10] Gelbenegger G, Jilma B. Clinical pharmacology of antiplatelet drugs[J]. Expert Rev Clin Pharmacol, 2022, 15(10): 1177-1197.
[11] Jansen P, Conrads G, Wenzler JS, et al. Bacteremia prevention during periodontal treatment-an in vivo feasibility study[J]. Antibiotics, 2023, 12(10): 1555.
[12] Herman WW, Konzelman JL Jr, Sutley SH. Current perspectives on dental patients receiving coumarin anticoagulant therapy[J]. J Am Dent Assoc, 1997, 128(3): 327-335.
[13] Wahl MJ. Dental surgery and antiplatelet agents: bleed or die[J]. Am J Med, 2014, 127(4): 260-267.
[14] Elad S, Marshall J, Meyerowitz C, et al. Novel anticoagulants: general overview and practical conside-rations for dental practitioners[J]. Oral Dis, 2016, 22(1): 23-32.
[15] Lapostolle F, Siguret V, Martin AC, et al. Vitamin K antagonists and emergencies[J]. Eur J Emerg Med, 2018, 25(6): 378-386.
[16] Kietaibl S, Ahmed A, Afshari A, et al. Management of severe peri-operative bleeding: guidelines from the European society of anaesthesiology and intensive care: second update 2022[J]. Eur J Anaesthe-siol, 2023, 40(4): 226-304.
[17] 孟焕新. 牙周病学[M]. 5版. 北京: 人民卫生出版社, 2020: 96-111.
Meng HX. Periodontology[M]. 5th ed. Beijing: People’s Medical Publishing House, 2020: 96-111.
[18] Frank C, Dana J, Alan JC, et al. Risks associated with discontinuation of oral anticoagulation in newly diagnosed patients with atrial fibrillation: results from the GARFIELD-AF registry[J]. J Thromb Haemost, 2021, 19(9): 2322-2334.
[19] 熊雪, 李海磊, 舒春花, 等. 静脉血栓栓塞症风险评估工具的研究进展[J]. 中国当代医药, 2023, 30(34): 28-31.
Xiong X, Li HL, Shu CH, et al. Research progress of risk assessment tools for venous thromboembolism[J]. China Mod Med, 2023, 30(34): 28-31.
[20] 刘凤林, 张太平. 中国普通外科围手术期血栓预防与管理指南[J]. 中国实用外科杂志, 2016, 36(5): 469-474.
Liu FL, Zhang TP. Chinese guidelines for perioperative thrombosis prevention and management in gene-ral surgery[J]. Chin J Pract Surg, 2016, 36(5): 469-474.
[21] Drisko CH. Nonsurgical periodontal therapy[J]. Pe-riodontol 2000, 2001, 25: 77-88.
[22] Delgado V, Ajmone Marsan N, de Waha S, et al. 2023 ESC Guidelines for the management of endocarditis[J]. Eur Heart J, 2023, 44(39): 3948-4042.
[23] Boccatonda A, Frisone A, Lorusso F, et al. Periope-rative management of antithrombotic therapy in patients who undergo dental procedures: a systematic review of the literature and network meta-analysis[J]. Int J Environ Res Public Health, 2023, 20(7): 5293.
[24] 王文英, 崔念晖, 王恩博, 等. 华法林对老年人拔牙术后出血影响的临床观察[J]. 中华口腔医学杂志, 2013, 48(7): 385-387.
Wang WY, Cui NH, Wang EB, et al. Clinical oberservation of influence of wafarin on post- operative bleeding after tooth extraction in the elderly[J]. Chin J Stomatol, 2013, 48(7): 385-387.
[25] 刘晓辉, 宋景春, 张进华, 等. 中国抗血栓药物相关出血诊疗规范专家共识[J]. 解放军医学杂志, 2022, 47(12): 1169-1179.
Liu XH, Song JC, Zhang JH, et al. Expert consensus on the standardization of diagnosis and treatment of antithrombotic drug-associated hemorrhage in China[J]. Med J Chin PLA, 2022, 47(12): 1169-1179.
[26] Godier A, Dincq AS, Martin AC, et al. Predictors of pre-procedural concentrations of direct oral anti-coagulants: a prospective multicentre study[J]. Eur Heart J, 2017, 38(31): 2431-2439.
[27] Association AD. Anticoagulant and antiplatelet me-dications and dental procedures[EB/OL]. [2022-09-28]. .
[28] Oprea AD, Noto CJ, Halaszynski TM. Risk stratification, perioperative and periprocedural management of the patient receiving anticoagulant therapy[J]. J Clin Anesth, 2016, 34: 586-599.
[29] 中国心胸血管麻醉学会非心脏麻醉分会, 中国医师协会心血管内科医师分会, 中国心血管健康联盟. 抗血栓药物围手术期管理多学科专家共识[J]. 中华医学杂志, 2020, 100(39): 3058-3074.
Chinese Society of Cardiothoracic and Vascular A-nesthesia, Non-cardiac Anesthesia Branch, Chinese College of Cardiovascular Physicians, China Cardiovascular Health Alliance. Multidisciplinary expert consensus on perioperative management of antithrombotic drugs[J]. Nat Med J China, 2020, 100(39): 3058-3074.
[30] Szumita RP, Szumita PM. Hemostasis in dentistry[M]. St. Louis, MO: Springer International Publi-shing, 2018.
[31] Douketis JD, Spyropoulos AC, Murad MH, et al. Perioperative management of antithrombotic therapy: an American college of chest physicians clinical practice guideline[J]. Chest, 2022, 162(5): e207-e243.
[32] Maulaz AB, Bezerra DC, Michel P, et al. Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke[J]. Arch Neurol, 2005, 62(8): 1217-1220.
[33] Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment ele-vation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardio-logy (ESC)[J]. Eur Heart J, 2018, 39(2): 119-177.
[34] Maier CL, Sniecinski RM. Anticoagulation monito-ring for perioperative physicians[J]. Anesthesiology, 2021, 135(4): 738-748.
[35] Rodeghiero F, Pabinger I, Ragni M, et al. Fundamentals for a systematic approach to mild and mode-rate inherited bleeding disorders: an EHA consensus report[J]. Hemasphere, 2019, 3(4): e286.
[36] McGrath C, Clarkson J, Glenny AM, et al. Effectiveness of mouthwashes in managing oral diseases and conditions: do they have a role[J]. Int Dent J, 2023, 73(): S69-S73.
[37] Zaib A, Shaheryar M, Shakil M, et al. Local tra-nexamic acid for preventing hemorrhage in anticoa-gulated patients undergoing dental and minor oral procedures: a systematic review and meta-analysis[J]. Healthcare, 2022, 10(12): 2523.
[38] 丁芳, 吕亚林, 宣玮, 等. 口服阿司匹林患者牙周机械治疗的出血控制[J]. 北京大学学报(医学版), 2017, 49(1): 49-53.
Ding F, Lü YL, Xuan W, et al. Bleeding control of periodontal mechanical therapy for patients taking aspirin[J]. J Peking Univ (Health Sci), 2017,49(1): 49-53.
[39] Zhang SH, Li JW, Chen SJ, et al. Oxidized cellulose-based hemostatic materials[J]. Carbohydr Polym, 2020, 230: 115585.
[40] 方超, 左键, 刘冬宇, 等. 服用双抗药物冠心病患者牙周洁治术后出血局部止血方法疗效比较[J]. 中国临床医生杂志, 2022, 50(6): 738-742.
Fang C, Zuo J, Liu DY, et al. Comparison of the curative effect of local hemostatic methods in patients with coronary heart disease after periodontal scaling[J]. Chin J Clin, 2022, 50(6): 738-742.
[41] Zanetto A, Rinder HM, Senzolo M, et al. Reduced clot stability by thromboelastography as a potential indicator of procedure-related bleeding in decompensated cirrhosis[J]. Hepatol Commun, 2020, 5(2): 272-282.
[42] Napeñas JJ, Oost FC, DeGroot A, et al. Review of postoperative bleeding risk in dental patients on antiplatelet therapy[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2013, 115(4): 491-499.
[43] Hoffmann B, Erwood K, Ncomanzi S, et al. Mana-gement strategies for adult patients with dental anxie-ty in the dental clinic: a systematic review[J]. Aust Dent J, 2022, 67(): S3-S13.
[44] Buchbender M, Schlee N, Kesting MR, et al. A prospective comparative study to assess the risk of postoperative bleeding after dental surgery while on medication with direct oral anticoagulants, antiplatelet agents, or vitamin K antagonists[J]. BMC Oral Health, 2021, 21(1): 504.
[45] Amato R, Caton J, Polson A, et al. Interproximal gingival inflammation related to the conversion of a bleeding to a nonbleeding state[J]. J Periodontol, 1986, 57(2): 63-68.
[46] 马赫. 长期口服阿司匹林患者不停药牙周非手术治疗出血情况观察[J]. 北京医学, 2020, 42(9): 893-896.
Ma H, Periodontal non-surgical bleeding in patients taking long-term oral aspirin without stopping medication[J]. Beijing Med J, 2020, 42(9): 893-896.
[47] Aslam RD, Liew J, Besi E. Is 1∶1 000 adrenaline as a topical haemostat an effective alternative to control bleeding in dentistry and oral surgery[J]. Br Dent J, 2023, 235(1): 29-34.
[48] Arad M, Goli R, Parizad N, et al. Do the patient education program and nurse-led telephone follow-up improve treatment adherence in hemodialysis patients? A randomized controlled trial[J]. BMC Nephrol, 2021, 22(1): 119.
[1] 李欢,原韶钟. 牙周炎与非酒精性脂肪性肝病相关性的研究进展[J]. 国际口腔医学杂志, 2025, 52(5): 677-683.
[2] 祝舒钰,周静,谢志刚. 辅助性T细胞17与调节性T细胞之间的制衡效应调控口腔颌面部骨损伤修复的研究进展[J]. 国际口腔医学杂志, 2025, 52(4): 514-525.
[3] 于寰,康健. 牙周内镜在口腔临床诊疗中的应用进展[J]. 国际口腔医学杂志, 2025, 52(4): 544-551.
[4] 李天元, 朱彤欣, 柳庆, 董迎春, 陈斌. 间充质干细胞用于牙周再生临床疗效的系统评价与Meta分析[J]. 国际口腔医学杂志, 2025, 52(3): 296-307.
[5] 别梦瑶,周婕妤,吴亚菲,赵蕾. 牙龈卟啉单胞菌影响血管平滑肌细胞调节性细胞死亡及表型转换的研究进展[J]. 国际口腔医学杂志, 2025, 52(3): 308-316.
[6] 范兴丽,潘乐,赵家园,项秋猛,陈启林. 竞争性内源性RNA在牙周炎中的作用及机制的研究进展[J]. 国际口腔医学杂志, 2025, 52(3): 317-322.
[7] 赵美林,赵依琼,黄姣. Ⅲ期C级牙周炎正畸患者上前牙龈乳头缺陷伴牙龈退缩1例[J]. 国际口腔医学杂志, 2025, 52(3): 333-340.
[8] 李晶,康健. 牙周微创手术中再生材料选择及疗效的研究进展[J]. 国际口腔医学杂志, 2025, 52(2): 161-168.
[9] 张潇月,陈舒泽,周婕妤,程磊,赵蕾. 具核梭杆菌经铁死亡途径破坏体外肠道上皮屏障模型的研究[J]. 国际口腔医学杂志, 2025, 52(2): 183-194.
[10] 钟良军. 数字化技术在重度牙周炎治疗中的应用[J]. 国际口腔医学杂志, 2025, 52(1): 1-10.
[11] 程守正,李太文,赵蕾. 血清淀粉样蛋白A与牙周炎相关性的研究进展[J]. 国际口腔医学杂志, 2025, 52(1): 117-122.
[12] 陈梦洁,徐文华,刘青青,康毓聃,刘蓉,朱丽雷. 全身免疫炎症指数与牙周炎患者分级诊断的相关性研究[J]. 国际口腔医学杂志, 2024, 51(6): 706-712.
[13] 陈蕊,范桢,郝春波. 黑色素瘤缺乏因子2炎症小体在牙周炎及糖尿病中的研究进展[J]. 国际口腔医学杂志, 2024, 51(6): 763-771.
[14] 毛鸿晨,王铮,杨德琴. 牙龈卟啉单胞菌外膜囊泡在口腔疾病中的作用及其机制的研究进展[J]. 国际口腔医学杂志, 2024, 51(5): 608-615.
[15] 漆美瑶,祁星颖,周欣奕,谭震,袁泉. 大麻二酚联合米诺环素对牙周炎治疗作用的实验研究[J]. 国际口腔医学杂志, 2024, 51(4): 392-400.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] 鲁少文 税艳青. 牙周膜干细胞的研究进展[J]. 国际口腔医学杂志, 2013, 40(6): 769 -772 .